Gabon vs South Africa: Number of people requiring preventive treatment for schistosomiasis
Gabon
204,568 people
in 2024
South Africa
506,732 people
in 2024
Gabon rank
42nd
South Africa rank
39th
Number of people requiring preventive treatment for schistosomiasis over time
- Gabon
- South Africa
How they compare
South Africa currently reports 506,732 people against 204,568 people in Gabon, a difference of 302,164 people.
That makes South Africa's figure about 2.5 times Gabon's.
Across all 15 years both countries report, South Africa has been ahead every year.
Gabon ranks 42nd and South Africa ranks 39th of 52 countries.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gabon | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 274,188 people | 5.28 million people | 5.01 million people | South Africa |
| 2020s | 192,392 people | 2.98 million people | 2.79 million people | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of people requiring preventive treatment for schistosomiasis, Gabon or South Africa?
- South Africa, at 506,732 people against 204,568 people in Gabon as of 2024.
- What is the difference in number of people requiring preventive treatment for schistosomiasis between Gabon and South Africa?
- 302,164 people, with South Africa ahead.
- How many years of comparable data are there for Gabon and South Africa?
- 15 years are reported by both, from 2010 to 2024.
- How do Gabon and South Africa rank globally for number of people requiring preventive treatment for schistosomiasis?
- Gabon ranks 42nd and South Africa ranks 39th of 52 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Number of people requiring preventive treatment for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Population requiring preventive chemotherapy for schistosomiasis.